Industry News

FDA approves first long-acting recombinant coagulation Factor IX concentrate for patients with Hemophilia B
Dainippon Sumitomo Pharma and Takeda Announce the European Marketing Authorization for Latuda (lurasidone) - a New Atypical Antipsychotic Medication for Adults with Schizophrenia
Dainippon Sumitomo Pharma and Takeda Announce the European Marketing Authorization for Latuda (lurasidone) - a New Atypical Antipsychotic Medication for Adults with Schizophrenia
CytRx Initiates Pivotal Global Phase 3 Clinical Trial with Aldoxorubicin for Second-Line Treatment of Soft Tissue Sarcoma
Ferring Pharmaceuticals Inc. Receives FDA Approval for the First and Only Mixed Protocol IVF Treatment -- Combines MENOPUR menotropins for injection... Pharmaceutical Companies
Actavis and Valeant Report FDA Approval for Metronidazole 1.3%
Actavis and Valeant Report FDA Approval for Metronidazole 1.3%
Draft Guidance for Industry on Labeling for Human Prescription Drug and Biological Products Approved Under the Accelerated Approval Regulatory...
FDA approves oral drug for psoriatic arthritis
FDA Staff Says Novartis' Serelaxin Shouldn't Be Approved
GlaxoSmithKline Reports alli Product Tampering, Alerts Consumers To Unknown Product In alli Packages
GlaxoSmithKline Reports alli� Product Tampering, Alerts Consumers To Unknown Product In alli� Packages
Draft Guidance for Industry on Labeling for Human Prescription Drug and Biological Products Approved Under the Accelerated Approval Regulatory...
BioRestorative Therapies Signs Research and Development Agreement with Rohto Pharmaceutical
Skinvisible's Sunscreen Meets New FDA Guidelines for Broad Spectrum and 80 Minute Water-Resistant Claims Plus Invisicare Patent Supports Eight Hours of Sunscreen Stabilization
BioRestorative Therapies Signs Research and Development Agreement with Rohto Pharmaceutical
Skinvisible's Sunscreen Meets New FDA Guidelines for Broad Spectrum and 80 Minute Water-Resistant Claims Plus Invisicare Patent Supports Eight Hours of Sunscreen Stabilization
Draft Guidance for Industry on Labeling for Human Prescription Drug and Biological Products Approved Under the Accelerated Approval Regulatory...
FDA approves Xolair (omalizumab) for people with Chronic Idiopathic Urticaria, a form of chronic hives
Focus Diagnostics Receives FDA Clearance for Moderate Complexity Simplexa� HSV 1 & 2 Direct Molecular Test for Aiding the Diagnosis of Encephalitis Quest Diagnostics business launches first HSV PCR for CSF in United States. Test provides results in
LUPIN LAUNCHES GENERIC NIASPAN TABLETS IN US MARKET
FDA Grants Diazyme 510(k) Clearance to Market Its Vitamin D Assay for Clinical Chemistry Analyzers
New consensus reached to help tackle multidrug-resistant and extensively drug-resistant TB
Approval to initiate FDA phase 2 study for molluscum contagiosum
Study: Non-Opioid Creams Relieve Pain, Improve Quality of Life in Senior Americans, While Reducing Use of Addicting Medicines Scientific Study Results to be Presented at Academy of Managed Care Pharmacy's Annual Meeting